TFX Teleflex Inc

Teleflex now provides a complete product offering across the continuum of care for vascular access with its ARROW® Vascular Access Products and EZ-IO® Devices

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will be showcasing ARROW® Vascular Products along with the newly acquired Vidacare vascular product line at the annual Society of Critical Care Medicine, January 9-13 in San Francisco, California. Vidacare produces the EZ-IO® Intraosseous Vascular Access System which delivers vascular access directly through the bone. With the acquisition of Vidacare finalized December 2, 2013, Teleflex is further positioned to offer clinicians the right vascular access line for the right patient at the right time.

In addition to a full line of Vascular Access solutions, Teleflex is committed to supporting clinical education. Teleflex, under the Vidacare brand, will be sponsoring an Advanced Invasive Procedures Laboratory with cadavers. Clinicians will be learning the latest in invasive procedural skills translating these skills directly to patient care.

Teleflex has built its vascular portfolio on the philosophy of Vessel Health and Preservation® Protocol, striving to provide The Right Line for The Right Patient at The Right Time™. The ARROW® Brand offers a full portfolio of vascular access products, including CVCs, PICCs, Arterial Lines and the newly released JACC catheter to provide choices for their patients. The addition of the EZ-IO® Intraosseous Vascular Access System adds another option for clinicians to consider in emergent or difficult vascular access situations. Furthermore, only Teleflex offers exclusive vascular access technologies such as Chlorag+ard® Technology (Antimicrobial / Antithrombogenic Catheter Protection) and VPS® Technology (Doppler and ECG Catheter Tip Location).

“We are thrilled to have the Vidacare vascular products joining the ARROW® Vascular Access family,” states Jay White, President Vascular Access Division. “We believe in offering life-saving devices like the EZ-IO® Intraosseous Vascular Access System to help clinicians achieve best outcomes for their patients. The ARROW® Brand has been bringing innovative solutions to market during its 35 year history, and we look forward to continuing this tradition at this year’s SCCM meeting.”

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,400 people worldwide and serves healthcare providers in more than 140 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, Arrow, Chlorag+ard, EZ-IO, The Right Line for The Right Patient at The Right Time, Vessel Health and Preservation and VPS are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.© 2014 Teleflex Incorporated. All rights reserved. 2013-2527

Teleflex IncorporatedJake ElguiczeTreasurer and Vice President, Investor Relations610-948-2836

Teleflex (NYSE:TFX)
Historical Stock Chart
From Aug 2024 to Sep 2024

Teleflex (NYSE:TFX)
Historical Stock Chart
From Sep 2023 to Sep 2024